This HTML5 document contains 206 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q24235724
rdf:type
wikibase:Item
schema:description
2010년 논문 სამეცნიერო სტატია bilimsel makale επιστημονικό άρθρο vetenskaplig artikel wetenskaplike artikel artikull shkencor artículu científicu espublizáu en 2010 videnskabelig artikel (udgivet 2010/12/08) 2010 nî lūn-bûn vedecký článok (publikovaný 2010/12/08) 2010年论文 научная статья article científic artigo científico (publicado na 2010) scienca artikolo سائنسی مضمون 2010年論文 2010年论文 teaduslik artikkel 2010年论文 articolo scientifico (pubblicato il 2010/12/08) article scientifique (publié 2010/12/08) mokslinis straipsnis 2010年论文 2010年論文 vitenskapelig artikkel мақолаи илмӣ vědecký článek publikovaný v roce 2010 wetenschappelijk artikel (gepubliceerd op 2010/12/08) tieteellinen artikkeli artículo científico publicado en 2010 article scientific vitskapeleg artikkel 2010年論文 научна статия научни чланак artikulong pang-agham artykuł naukowy 2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած tudományos cikk ശാസ്ത്ര പ്രബന്ധം scientific article 2010年論文 مقالة علمية (نشرت في 8-12-2010) 2010年论文 2010年の論文 научни чланак мақолаи илмӣ naučni članak artigo científico (publicado na 2010/12/08) ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bài báo khoa học наукова стаття, опублікована в грудні 2010 บทความทางวิทยาศาสตร์ 2010年論文 2010年论文 wissenschaftlicher Artikel (veröffentlicht am 8 Dezember 2010) מאמר מדעי مقالهٔ علمی articol științific artigo científico 2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
p:P577
wds:Q24235724-708CE964-1D8E-4CDA-8D8B-512694ED9202
wdt:P577
2010-12-08T00:00:00Z
p:P2860
wds:Q24235724-BC5BB603-56A3-4803-93DF-4925E066839C wds:Q24235724-C05B988D-B0D3-48E9-AB80-288ED2CE392B wds:Q24235724-C7CFF0E0-DD77-4CC9-AA58-69C6118571EE wds:Q24235724-CB7974FF-6C17-4305-A954-E39BB5CBD6DC wds:Q24235724-CB7F9283-D255-43AB-9DDE-7295C9FEB3E0 wds:Q24235724-CF63E126-B175-40A5-AAA1-9D4885816B15 wds:Q24235724-D221F0EF-E911-43E6-931D-A838F28FAD80 wds:Q24235724-D5E58607-B2C7-43B6-A62D-68DC26220463 wds:Q24235724-D88C8122-D625-4A2E-8447-EB9AFD2348FE wds:Q24235724-E38F4C85-EAFD-4026-9186-3FE89E9B7D9B wds:Q24235724-E5DC19DC-5807-4735-B403-0795D6C23860 wds:Q24235724-E62CD22F-6536-4AE5-B6B4-F345CB96D1AC wds:Q24235724-E9679BE2-BC77-43BE-A211-07C025B8F5FD wds:Q24235724-EB943425-6D7B-4C79-AA5F-7360F1E7FDC3 wds:Q24235724-ED0BA1CA-BDD9-43F2-AAC4-29BE49960375 wds:Q24235724-EF8FC269-6E60-4608-9F89-0A84845C6AB4 wds:Q24235724-F3715305-7D95-4941-AD34-FDBC6FAAE52B wds:Q24235724-F925A116-30E0-4F81-AE43-F4F1C204EA16 wds:Q24235724-FA8F138D-8690-4F19-9EB9-D3DEF6100B2D wds:Q24235724-31664F76-1FFC-44C4-8D59-D10BF9E4F104 wds:Q24235724-37DD0CCA-CCAB-4BC2-8E40-50AFE2F847AD wds:Q24235724-39E434DF-781A-44FF-8A6B-35D9686D9922 wds:Q24235724-39F8EF68-AD55-4379-9B93-5E81C8B55317 wds:Q24235724-3C9995E1-99A3-4AC4-B641-D3917060F6DB wds:Q24235724-438152EA-68F0-4EDE-996A-B34FBAF71E7F wds:Q24235724-523DF3A7-936B-4668-A2C7-E95A2653F8F8 wds:Q24235724-66DBD8C0-72FC-491F-B502-001C4EF0E758 wds:Q24235724-6A825267-DCAD-4B80-ABFD-736FD5DF588D wds:Q24235724-7046EE7B-A520-46D3-A54F-64166DD44E80 wds:Q24235724-78B61DD6-9A60-45A0-916A-B687C50CFAC5 wds:Q24235724-81700399-1D77-4B53-BF27-3EA167513E03 wds:Q24235724-8387ABA0-44B9-4A14-93F0-F22B69C8F664 wds:Q24235724-87E61F59-4C5F-440D-A723-CB8F9DCE7724 wds:Q24235724-95253535-131E-4510-BF35-D4D036082D1E wds:Q24235724-9885298C-B882-4E4A-9F12-C730E5772A96 wds:Q24235724-9A4D2C2B-682B-4932-A0BD-8BCD81862492 wds:Q24235724-9A6856EB-AB5C-428A-BD21-7DE47EB473DC wds:Q24235724-9ECD57CD-4096-42BE-97A0-351F8B5EA4D6 wds:Q24235724-ADB31BDB-1CB4-49C5-A8CC-528450E4E204 wds:Q24235724-B05605EC-128C-45B3-BE4A-AE86028DAA4D wds:Q24235724-B177BB7B-00EA-48C0-A1E1-D7EED4CD9201 wds:Q24235724-B4F87AA6-384F-41FB-9C37-BB3039CFF7DD wds:Q24235724-038446A7-5F1C-4714-9C15-1AE0259702AE wds:Q24235724-1284234E-B731-4E0F-BFE5-896720B61A20 wds:Q24235724-1316159B-79E5-4A52-9C0B-DDAFC3F45C9F wds:Q24235724-1540EE1F-1740-425A-8733-74C093397D36 wds:Q24235724-1BD92954-993A-44D2-9015-B6F8AFC31186 wds:Q24235724-304200ED-CD00-4B59-A8A0-6D140392A75C
wdt:P2860
wd:Q46571863 wd:Q44794035 wd:Q46447967 wd:Q45398049 wd:Q36285950 wd:Q43820991 wd:Q34658625 wd:Q44660478 wd:Q38450995 wd:Q44386599 wd:Q36738171 wd:Q37234205 wd:Q61895315 wd:Q43935752 wd:Q46173768 wd:Q46150625 wd:Q43646768 wd:Q27860753 wd:Q34658632 wd:Q29620610 wd:Q33429719 wd:Q51777826 wd:Q81285277 wd:Q44849439 wd:Q46923095 wd:Q46559774 wd:Q35097400 wd:Q52065697 wd:Q24627714 wd:Q44198482 wd:Q45270618 wd:Q61895314 wd:Q46807885 wd:Q29547281 wd:Q45010903 wd:Q45279098 wd:Q42170053 wd:Q24802369 wd:Q37137838 wd:Q34402447 wd:Q34546335 wd:Q42990738 wd:Q45383777 wd:Q43818117 wd:Q44108848 wd:Q24246038 wd:Q44184848 wd:Q46269343
p:P2093
wds:Q24235724-291BB245-4C2D-46C7-8F1E-DCC037C9FA84 wds:Q24235724-28E246C1-1E10-4BBD-9F81-4ECBFE3E29C6 wds:Q24235724-34DE8AAD-E2DD-4E4B-A7DD-AD39C008DEA1 wds:Q24235724-5660FFEE-E258-4221-8D21-BCD6E64FAA51
wdt:P2093
James H Irlam Lawrence CE Mbuagbaw Alicen Spaulding George W Rutherford
rdfs:label
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals
skos:prefLabel
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals
schema:name
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals
p:P50
wds:Q24235724-7F63D8FB-AD71-4880-BECF-72519274B9CF
wdt:P50
wd:Q28039178
p:P1476
wds:Q24235724-ACC92545-295C-42AB-9630-1AB58DDC2CE1
wdt:P1476
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals
p:P31
wds:Q24235724-a0d241c0-47cd-43b4-b9e1-e4c9fc7d4800 wds:Q24235724-fd169061-87ac-47f3-af6d-b009780ff597 wds:Q24235724-9D0AD900-4A5C-4B96-AA81-D480F6CDA5E6
wdt:P31
wd:Q13442814 wd:Q815382 wd:Q7318358
p:P921
wds:Q24235724-3682A010-75A2-4CDC-A219-7F34F66D9DAC wds:Q24235724-8EA2E572-D229-4314-B68D-26B1F9A44B9C wds:Q24235724-D956D83D-14D1-421F-BEA6-9C235190D026
wdt:P921
wd:Q50430310 wd:Q263713 wd:Q422645
p:P698
wds:Q24235724-FECF9EC4-62E6-47D9-BA05-4180228125DE
wdtn:P698
n11:21154355
wdt:P698
21154355
p:P1433
wds:Q24235724-EA4406D9-F316-4F1A-87B6-E45F434B3CF5
wdt:P1433
wd:Q15750361
p:P356
wds:Q24235724-6DF50648-B879-4661-A574-A7940823CBB2
wdtn:P356
n10:14651858.CD004246.PUB3
wdt:P356
10.1002/14651858.CD004246.PUB3